COSMETIC COMPOSITIONS OF MITOCHONDRIALLY TARGETED ANTIOXIDANTS

Abstract
Dislosed are compositions comprising SkQ1 for protection of the skin from damage caused by free radicals and/or re active oxygen species.
Description
SPHERE OF APPLICATION

This invention relates to biology and medicine and in particular to cosmetology, and may be used for manufacturing a composition for protecting the skin from damage caused by free radicals and/or active forms of oxygen.


TECHNICAL FIELD OF INVENTION

Mitochondrially targeted antioxidants (MTA) are one of the most promising classes of anti-age products for use in various products including cosmetic products. However, various MTAs, including those in the SkQ class, in multi-component liquid mixtures are not greatly stable over long periods of storage (over 30 days). The prior art refers to a number of versions of stable compositions of MTA (see for example application WO2012167236), but the number of compositions discovered in technical terms is extremely limited for application as a finished cosmetic product. Therefore, the creation of a finished cosmetic product containing a MTA, and particularly SkQ-class compounds, with sufficient storage stability is an unresolved technical task.


Definitions


1. Mitochondrial antioxidant—compound with general formula 1:




embedded image


Where A is an antioxidant with general formula 2:




embedded image


Where Y where m is an integer from 1 to 3; Y refers to single or various substitutes that constitute a lower alkyl or lower alkoxy, including the methyl or methoxy groups;


and/or its restored form


L is a linker group, that is:


a) a straight or branched hydrocarbon chain, not necessarily replaced with one or more substitutes, and where necessary containing one or more double or triple bonds; or


b) a natural isoprenoid chain;


n is an integer from 1 to 20;


B is a Skulachev ion Sk:





Sk+Z


where Sk is a lipophilic cation; Z is a pharmacologically acceptable anion


2. Stable composition for cosmetic use is a composition within which the formula 1 compound retains sufficient stability over at least 30 days when stored at a temperature of +5° C.


3. Emollients are substances from various chemical groups, hydrophilic and lipophilic, capable of softening the skin.


4. Multifunctional components are components of a cosmetic product that fulfil more than one function.


Names and Description of Some Components of Finished Cosmetic Products and Their Manufacturers:


(manufacturers shown in square brackets)


Application of the invention is not limited to use of the specific components shown (trade names) or specifically these manufacturers. The composition of components is significant, and the manufacturer and trade product may be different. Manufacturers and trade names are shown as proof of possibility of applying the invention and as an indication for qualified specialists of what ingredients (regardless of their trade names and manufacturers) were used in the present invention.


Biocol LG (Ceratonia Siliqua Gum, Pectin, Algin) [Manufacturer: Biogenico Worldwide].


Biocol AX (Pectin, Xanthan Gum) [Biogenico Worldwide].


Makimousse12 (Sodium Polyacrylate Starch) [Daito Kasei].


Methocel 40-202 (Hydroxypropyl Methylcellulose) [DOW].


Nexbase 2006 FG (Hydrogenated Polydecene) [Neste Oil Oyj].


Silsoft 034 (Caprylyl Methicone) [Momentive Performance Materials].


Sensolene (Ethyl hexyl Olivate) [B@TCompany].


Lexfeel 7 (Neopentyl Glycol Diheptanoate) [Inolex].


Biolin/P (Inulin, Alpha-glucan Oligosaccharide) [Goya Ingredients].


Drieline1s (Sorbitol, Yeast Extract) [LucasMeyer cosmetics].


Peptiskin (Arginine/lysine Polypeptide) [Solabia Group].


Gatuline In-Tense (Caprylic/Capric Triglyceride, Spilanthes Acmella Flower Extract) [Gattefosse].


Vegetensor (Pisum Sativum Extract, Sclerotium Gum) [Alban Muller International].


Argireline (Aqua, Acetyl Hexapeptide-8) [Lipotec Group].


Ecoffea (Aqua, Glycerine, Coffea Arabica (Coffee) Seedcake Extract) [Chemyunion Quimica LTDA].


Dermocea (Aqua, Sucrose, Meristotheca Dakarensis Extract, Jania Rubens Extract) [Gelyma].


RonaCare Cyclopeptide-5 (Aqua, Alcohol, Lecithin, Ectoin, Cyclotetrapeptide-24 Aminocyclohexane Carboxylate) [Merck KGaA].


RonaCare Luremin (Dihydroxymethylchromone, Sorbitol) [Merck KGaA].


RonaFlair MTU (Bismuth Oxychloride) [Merck KGaA].


Colorona Oriental Beige (Mica, C177891 (TiO2), C177491 (FeO)) [Merck KGaA].


Colorona Red Gold (Mica, Titanium Dioxide, Iron Oxide) [Merck KGaA].


Microcare IT (Methylchloroisothiazolinone, Methylisothiazolinone) [Thor Sp].


Dipotassium Glycyrrhizate [Selco].


Ethyl Ascorbic Acid [Selco].


Allantoin [DSM]


D-Panthenol [DSM]


Sodium Ascorbyl Phosphate. [BASF]


Propylene Glycol. [INEOS].


Hydrolite-5 (Pentylene Glycol) [Symrise].


Sensiva SC 50 (Ethyl hexyl glycerine) [Schulke@Mayr].







DESCRIPTION OF INVENTION

The present invention provides a composition and manufacturing process for finished multi-component cosmetic products containing MTAs. Overall, the key aspect of the invention is stable cosmetic composition containing mitochondrial antioxidant, and at least one additional component from the following list: gel-forming component, emollient, multi-functional component with antimicrobial activity, additional component—active cosmetic ingredient.


Examples (not limited to scope of claims under the present invention) are the following compositions:
















Component
Concentration
















Composition 1










SkQ1
 1 nM-1 mM



Gel-forming agent Biocol LG (carob tree gum,
0.2-5%



pectin, sodium alginate)



Hydrogenated polydecene
0.01-40%



Caprylyl methicone
0.01-40%



Ethyl hexyl glycerine
0.1-2%



Pentylene glycol
 0.5-10%



Propylene glycol
  1-50%



Gatuline In-Tense
0.1-5%







Composition 2










SkQ1

   10 mcM




Gel-forming agent Biocol LG (carob tree gum,
2.9%



pectin, sodium alginate)



Hydrogenated polydecene
0.5%



Caprylyl methicone
0.5%



Ethyl hexyl glycerine
0.3%



Pentylene glycol
  5%



Propylene glycol
  3%



Gatuline In-Tense
  2%







Composition 3










SkQ1

   10 mcM




Gel-forming agent Biocol LG (carob tree gum,
2.9%



pectin, sodium alginate)



Hydrogenated polydecene
0.5%



Caprylyl methicone
0.5%



Ethyl hexyl glycerine
0.3%



Pentylene glycol
  5%



Propylene glycol
  3%



Gatuline In-Tense
  2%



Microcare IT (methylchloroisothiazolinone
0.1%



(and) methylisothiazolinone)







Composition 4 (on basis of exp. of sample 1)










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Benzalkonium chloride
0.01% 







Composition 5










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Hydrogenated polydecene (Nexbase)
  1%







Composition 6










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
  1%







Composition 7










SkQ1
0.1-1,000 mcM



Biocol MG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



D-panthenol
0.75% 







Composition 8










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Neopentyl glycol diheptanoate (Lexfeel 7)
  1%







Composition 9










SkQ1
0.1-1,000 mcM



Sodium Polyacrylate Starch (Makimousse 12)
  1%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%







Composition 10 (on base of exp. of example 2)










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Caprylic/Capric triglyceride (and) Spilanthes
  2%



Acmella Flower Extract (Gatuline In-Tense)







Composition 11










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Aqua (and) Acetyl Hexapeptide-8 (Argireline)
  5%







Composition 12










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Aqua (and) Glycerine (and) Coffea Arabica
  4%



(Coffee) Seedcake Extract (Ecoffea)







Composition 13










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Sorbitol (and) Methylchromone
  3%



(RonaCareLuremin)







Composition 14










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Bismuth Oxychloride (RonaFlair MTU)
  2%







Composition 15










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Mica (and) Titanium Dioxide (and) Iron Oxide
0.6%



(Colorona Red Gold)







Composition 16










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Aqua (and) Acetyl Hexapeptide-8 (Argireline)
  5%



Microcare IT (methylchloroisothiazolinone
0.1%



(and) methylisothiazolinone)







Composition 17 (on basis of exp. of example 3)










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



RonaCare Luremin
  3%







Composition 18










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



Ecoffea
  4%







Composition 19










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Argireline
  5%



RonaCare Luremin
  3%







Composition 20










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Argireline
  5%



Ecoffea
  4%







Composition 21










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Ecoffea
  4%



RonaCare Luremin
  3%







Composition 22










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



RonaCare Luremin
  3%







Composition 23










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



Ecoffea
  4%







Composition 24










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



RonaCare Luremin
  3%







Composition 25










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



Ecoffea
  4%







Composition 26










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Argireline
  5%



RonaCare Luremin
  3%







Composition 27










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Argireline
  5%



Ecoffea
  4%







Composition 28










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Ecoffea
  4%



RonaCare Luremin
  3%







Composition 29










SkQ1
0.1-1,000 mcM



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



RonaCare Luremin
  3%







Composition 30










SkQ1
0.1-1,000 mcM



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Gatuline In-Tense
1.8%



Ecoffea
  4%







Composition 31










SkQ1
0.1-1,000 mcM



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Argireline
  5%



RonaCare Luremin
  3%







Composition 32










SkQ1
0.1-1,000 mcM



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Argireline
  5%



Ecoffea
  4%







Composition 33










SkQ1
0.1-1,000 mcM



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



RonaCare Luremin
  3%



Ecoffea
  4%







Composition 34










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Argireline
  5%



RonaCare Luremin
  3%



Ecoffea
  4%







Composition 35










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
0.2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%







Composition 36 (on basis of exp. of example 4)










SkQ1
0.1-1,000 mcM



Methocel 40-202 (hydroxypropyl methyl
  2%



cellulose)



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%







Composition 37










SkQ1
0.1-1,000 mcM



Biocol LG
2.5%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%







Composition 38










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Caprylyl methicone (Silsoft 034)
0.5%



Hydrogenated polydecene (Nexbase)
0.5%



Additional compositions on basis of exp. of



example 1







Composition 39










SkQ1
0.1-1,000 mcM



Biocol LG
2.9%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%



Dipotassium glycyrrhizate
  1%







Composition 40










SkQ1
0.1-1,000 mcM



Sodium Polyacrylate Starch (Makimousse 12)
  1%



Propylene glycol
  3%



Pentylene glycol
  5%



Ethyl hexyl glycerine
0.3%










Other examples of compositions are compositions according to the table shown above, in which Biocol LG is replaced with Biocol AX. The experiment conducted showed that SkQ retrains its stability with such replacement.


Other examples of compositions are compositions containing 0.1-1,000 mcM of SkQ1 and Biocol of any type without emollients.


Another aspect of this invention is the method of manufacturing compositions containing a mitochondrial antioxidant. The said method includes the following procedures: addition to water of gel-forming agent (at temperature suitable for the gel-forming agent specifically chosen), mixing (for certain gel-forming agents after swelling, for certain gel-forming agents after the required pH value is reached), introduction of remaining active ingredients, in which case the oil-soluble active ingredients should preferably be introduced together with the hydrophobic emollients, and the mitochondrial antioxidant is introduced last.


EXPERIMENTAL EXAMPLES

The experimental samples shown below illustrate possible ways of applying the invention and do not in any measure limit the scope of claims for this invention.


All experiments concerning stability of the cosmetic components tested are conducted under a single plan. The composition was prepared by adding gel-forming agent to water at the corresponding temperature and pH. Depending on the type of gel-forming agent with mixing or withholding necessary to swell the component and/or achieve the specific pH values. Then, after mixing, the remaining components (oil-soluble active ingredients, together with hydrophobic emollients) and the mitochondrial antioxidant are added.


The mixture was then kept in darkness at different temperatures, and the mitochondrial antioxidant content levels were determined using the LCMS/MS method on a Waters TQD chromatographic mass spectrometer.


The quantitative analysis was conducted using the UPLC-MS/MS method with SkQ-d15 of a known concentration as the internal standard and 3-chlorperbenzoic acid as the oxidising agent. The analysis was conducted in accordance with the method shown in the PCS for Visomytin eye drops.


1 analytical sample was prepared from each sample (extraction of 1 ml of methanol 12 hours, thermoshaker (27° C. 1400 rpm), centrifuging, preparation of analytical samples with dilution 5 times).


Each standard sample was injected 6 times before every nine injections of analytical samples. S/Sstd for standard samples were averaged at 45 injections.


Experimental Example 1
File Cos16-Cos29

The basic composition (BC1) used in this experiment was a composition with the following ingredients:


Biocol LG—2.9%


Propylene glycol—3%


Pentylene glycol—5%


Ethyl hexyl glycerine—0.3%


SkQ1—2 mcM


The following versions of compositions were examined:














Compo-
Compo-



sition
sition



number
code
Ingredient

















1
Cos16
BC1 + benzalkonium chloride 0.01%


2
Cos17
BC1 + hydrogenated polydecene (Nexbase) 1%


3
Cos18
BC1 + caprylyl methicone (Silsoft 034) 1%


4
Cos19
BC1 + ethyl hexyl olivate (Sensolene) 1%


5
Cos20
BC1 + D-Panthenol 0.75%


6
Cos21
BC1 + neopentylglycol diheptanoate (Lexfeel 7) 1%


7
Cos22
BC1 + inulin in mixture with α-glucane




oligosaccharide (Biolin/P) 5%


8
Cos23
BC1 + Sorbitol in mixture with yeast extract




(Drieline) 1%


9
Cos24
BC1 + ethyl ascorbic acid 0.1%


10
Cos25
BC1 + dipotassium glycyrrhizate 1%


11
Cos26
BC1 + allantoin 0.3%


12
Cos27
BC1 + ethyl ascorbic acid 0.5%


13
Cos28
BC1 + sodium ascorbylphosphate 0.5%


14
Cos29
Sodium Polyacrylate Starch (Makimousse 12) 1% +




propylene glycol 3% + pentylene glycol 5% + ethyl




hexyl glycerine 0.3% + SkQ1









0-point: Samples of cosmetics after manufacture and weighing were stored at −78 . . . -80° C. in dark plastic bottles 2 ml in volume until the analysis was conducted.


Time points: Samples of cosmetics after manufacture and weighing were stored for a set number of months at 37° C. in dark plastic bottles 2 ml in volume then stored at −78 . . . -80° C. until the analysis was conducted.


Test preparation: Heating at room temperature (30 min), extraction with methanol (1 ml, vortex, thermoshaker 1.5 hours 1,200 rpm), centrifuging (15 min 13,400 rpm)


Numerical Material:























uG/mL


m(cos),
time,





Med
Ave
AveDev
AveDev %
mg
month
uG/g
AveDev
























Cos16
0.0493
0.0499
0.0010
2.1%
108.68
0.0
0.459
0.009



0.0378
0.0379
0.0002
0.6%
104.37
1.0
0.363
0.002



0.0355
0.0358
0.0005
1.3%
96.33
2.0
0.371
0.005



0.0311
0.0312
0.0004
1.1%
92.17
3.0
0.338
0.004



0.0323
0.0326
0.0006
1.8%
106
4.0
0.308
0.006



0.0307
0.0310
0.0004
1.4%
105.35
5.0
0.294
0.004



0.0284
0.0285
0.0002
0.7%
104.65
6.0
0.272
0.002



0.0265
0.0265
0.0002
0.7%
93.57
7.0
0.283
0.002



0.0247
0.0247
0.0001
0.6%
91.99
8.0
0.269
0.002


Cos17
0.0225
0.0228
0.0004
1.6%
91.58
0.0
0.249
0.004



0.0214
0.0215
0.0003
1.5%
105.19
1.0
0.204
0.003



0.0214
0.0213
0.0002
0.9%
110.66
2.0
0.193
0.002



0.0154
0.0154
0.0000
0.0%
110.39
3.0
0.139
0.000



0.0167
0.0166
0.0003
1.6%
96.15
4.0
0.172
0.003



0.0143
0.0143
0.0001
0.7%
91.22
5.0
0.156
0.001



0.0139
0.0140
0.0001
0.8%
109.17
6.0
0.128
0.001



0.0138
0.0140
0.0005
3.3%
111.5
7.0
0.125
0.004



0.0143
0.0142
0.0002
1.7%
108.9
8.0
0.130
0.002


Cos18
0.0372
0.0374
0.0007
2.0%
96.12
0.0
0.389
0.008



0.0316
0.0314
0.0008
2.4%
108.39
1.0
0.290
0.007



0.0232
0.0232
0.0002
0.9%
101.55
2.0
0.229
0.002



0.0208
0.0208
0.0001
0.5%
97.72
3.0
0.213
0.001



0.0186
0.0186
0.0002
0.9%
100.54
4.0
0.185
0.002



0.0174
0.0174
0.0004
2.3%
101.44
5.0
0.172
0.004



0.0169
0.0168
0.0004
2.1%
104.65
6.0
0.161
0.003



0.0188
0.0185
0.0005
2.7%
102.84
7.0
0.179
0.005



0.0179
0.0182
0.0006
3.4%
110.35
8.0
0.165
0.006


Cos19
0.0381
0.0379
0.0004
1.0%
106.13
0.0
0.358
0.003



0.0353
0.0352
0.0005
1.4%
105.31
1.0
0.335
0.005



0.0223
0.0223
0.0002
0.8%
94.35
2.0
0.236
0.002



0.0223
0.0221
0.0004
1.8%
97.05
3.0
0.227
0.004



0.0041
0.0041
0.0001
2.0%
110.82
4.0
0.037
0.001



0.0150
0.0150
0.0000
0.2%
100.39
5.0
0.149
0.000



0.0045
0.0046
0.0000
1.1%
99.97
6.0
0.046
0.000



0.0096
0.0097
0.0002
1.6%
103.46
7.0
0.093
0.002



0.0126
0.0126
0.0003
2.1%
99.27
8.0
0.127
0.003


Cos20
0.0374
0.0373
0.0004
1.1%
110.4
0.0
0.338
0.004



0.0307
0.0308
0.0002
0.6%
91
1.0
0.339
0.002



0.0238
0.0237
0.0004
1.6%
97.83
2.0
0.242
0.004



0.0348
0.0349
0.0003
0.7%
95.19
3.0
0.366
0.003



0.0223
0.0223
0.0003
1.1%
114.08
4.0
0.195
0.002



0.0228
0.0228
0.0002
1.1%
101.98
5.0
0.224
0.002



0.0174
0.0173
0.0001
0.6%
106.8
6.0
0.162
0.001



0.0191
0.0191
0.0002
0.9%
96.46
7.0
0.198
0.002



0.0178
0.0179
0.0001
0.7%
102.84
8.0
0.174
0.001


Cos21
0.0430
0.0429
0.0009
2.1%
103.54
0.0
0.414
0.009



0.0418
0.0416
0.0005
1.3%
92.57
1.0
0.450
0.006



0.0354
0.0353
0.0003
0.8%
101.06
2.0
0.349
0.003



0.0454
0.0456
0.0008
1.7%
106.21
3.0
0.430
0.007



0.0362
0.0364
0.0006
1.7%
97.27
4.0
0.374
0.006



0.0431
0.0433
0.0004
1.0%
110.68
5.0
0.391
0.004



0.0322
0.0321
0.0006
1.9%
108.25
6.0
0.296
0.006



0.0339
0.0340
0.0002
0.7%
90.59
7.0
0.375
0.002



0.0245
0.0243
0.0005
1.9%
98.83
8.0
0.246
0.005


Cos22
0.0372
0.0372
0.0007
1.8%
112.87
0.0
0.330
0.006



0.0203
0.0203
0.0000
0.0%
105.39
1.0
0.193
0.000



0.0147
0.0147
0.0000
0.0%
94
2.0
0.157
0.000



0.0139
0.0138
0.0002
1.6%
111.08
3.0
0.124
0.002



0.0087
0.0086
0.0001
1.5%
102.66
4.0
0.084
0.001



0.0083
0.0083
0.0000
0.1%
97.32
5.0
0.085
0.000



0.0060
0.0061
0.0001
1.7%
97.72
6.0
0.062
0.001



0.0059
0.0059
0.0001
1.4%
93.14
7.0
0.063
0.001



0.0063
0.0063
0.0000
0.3%
98.38
8.0
0.064
0.000


Cos23
0.0481
0.0480
0.0000
0.1%
104.9
0.0
0.458
0.000



0.0279
0.0277
0.0004
1.3%
109.68
1.0
0.253
0.003



0.0173
0.0174
0.0005
2.6%
87.64
2.0
0.199
0.005



0.0186
0.0188
0.0004
2.0%
89.39
3.0
0.210
0.004



0.0196
0.0198
0.0004
1.9%
107.85
4.0
0.184
0.003



0.0138
0.0139
0.0002
1.4%
94.48
5.0
0.147
0.002



0.0102
0.0102
0.0001
1.4%
91.4
6.0
0.112
0.002



0.0125
0.0126
0.0004
2.8%
95.03
7.0
0.133
0.004



0.0133
0.0134
0.0002
1.2%
107.99
8.0
0.124
0.001


Cos24
0.0393
0.0387
0.0010
2.7%
97.47
0.0
0.397
0.011



0.0197
0.0196
0.0003
1.5%
111.7
1.0
0.175
0.003



0.0085
0.0085
0.0001
1.5%
103.49
2.0
0.082
0.001



0.0153
0.0153
0.0003
2.0%
112.53
3.0
0.136
0.003



0.0116
0.0116
0.0001
0.5%
93.66
4.0
0.124
0.001



0.0096
0.0095
0.0001
1.0%
111.19
5.0
0.086
0.001



0.0050
0.0050
0.0001
1.2%
99.02
6.0
0.051
0.001



0.0065
0.0065
0.0001
1.4%
111
7.0
0.059
0.001



0.0053
0.0053
0.0001
2.8%
91.19
8.0
0.058
0.002


Cos25
0.0409
0.0405
0.0007
1.8%
89.09
0.0
0.454
0.008



0.0311
0.0307
0.0005
1.6%
109.77
1.0
0.280
0.004



0.0282
0.0279
0.0006
2.2%
107.22
2.0
0.260
0.006



0.0239
0.0239
0.0002
0.9%
93.9
3.0
0.254
0.002



0.0230
0.0231
0.0001
0.6%
98.16
4.0
0.235
0.001



0.0226
0.0226
0.0005
2.2%
110.1
5.0
0.205
0.004



0.0199
0.0198
0.0003
1.5%
100.61
6.0
0.196
0.003



0.0204
0.0205
0.0003
1.3%
111.4
7.0
0.184
0.002



0.0190
0.0191
0.0002
1.1%
108.37
8.0
0.177
0.002


Cos26
0.0446
0.0448
0.0005
1.0%
104.55
0.0
0.429
0.004



0.0226
0.0227
0.0002
0.8%
99.17
1.0
0.229
0.002



0.0188
0.0187
0.0002
1.2%
103.84
2.0
0.180
0.002



0.0171
0.0172
0.0002
0.9%
113.75
3.0
0.151
0.001



0.0110
0.0109
0.0002
2.2%
89.97
4.0
0.121
0.003



0.0106
0.0104
0.0002
2.2%
103.9
5.0
0.100
0.002



0.0078
0.0078
0.0001
1.6%
100.73
6.0
0.078
0.001



0.0080
0.0080
0.0000
0.0%
111.11
7.0
0.072
0.000



0.0059
0.0059
0.0000
0.0%
105.86
8.0
0.056
0.000


Cos27
0.0394
0.0404
0.0014
3.5%
95.99
0.0
0.421
0.015



0.0237
0.0235
0.0003
1.2%
100.15
1.0
0.235
0.003



0.0159
0.0159
0.0003
2.1%
94.61
2.0
0.168
0.003



0.0123
0.0121
0.0004
3.2%
96.31
3.0
0.125
0.004



0.0100
0.0101
0.0004
3.8%
109.65
4.0
0.092
0.004



0.0055
0.0055
0.0001
1.5%
104.03
5.0
0.053
0.001



0.0031
0.0032
0.0001
3.4%
111.45
6.0
0.028
0.001



0.0035
0.0034
0.0002
4.6%
112.73
7.0
0.030
0.001



0.0025
0.0025
0.0000
0.0%
105.36
8.0
0.024
0.000


Cos28
0.0454
0.0457
0.0005
1.1%
114.27
0.0
0.400
0.004



0.0091
0.0091
0.0001
0.7%
95.23
1.0
0.096
0.001



0.0050
0.0050
0.0000
0.6%
107.99
2.0
0.047
0.000



0.0026
0.0026
0.0001
3.6%
95.14
3.0
0.027
0.001



0.0020
0.0020
0.0000
0.9%
97.41
4.0
0.021
0.000



0.0017
0.0016
0.0001
3.7%
95.45
5.0
0.017
0.001



0.0012
0.0012
0.0001
5.3%
104.59
6.0
0.011
0.001



0.0010
0.0010
0.0000
3.1%
92.12
7.0
0.011
0.000



0.0013
0.0013
0.0001
5.6%
108.81
8.0
0.012
0.001


Cos29
0.0091
0.0091
0.0001
1.1%
106.2
0.0
0.085
0.001



0.0084
0.0083
0.0001
1.4%
103.75
1.0
0.080
0.001



0.0063
0.0065
0.0003
4.4%
98.44
2.0
0.066
0.003



0.0055
0.0055
0.0001
1.5%
87.85
3.0
0.063
0.001



0.0052
0.0051
0.0001
1.2%
104.62
4.0
0.049
0.001



0.0051
0.0051
0.0001
1.2%
102.09
5.0
0.050
0.001



0.0044
0.0044
0.0001
2.3%
95
6.0
0.047
0.001



0.0044
0.0044
0.0001
1.5%
98.51
7.0
0.044
0.001



0.0052
0.0053
0.0001
1.5%
103.27
8.0
0.051
0.001









On the basis of the kinetic curves and initial losses, the time taken to reach 20% losses, and residual SkQ1 content after 1 year of storage, were calculated. The values obtained were extrapolated to real conditions of storage at room temperature (25 C) and in refrigeration temperature (4 C). The values calculated are shown in the table.
















De-





gradation
Time taken to



speed
reach 80% of
Residual SkQ1



constant at
SkQ1 from added
content after year


Sample
37° C. k′,
total, months
of storage, %














number
month−1
37° C.
25° C.
4° C.
37° C.
25° C.
4° C.

















1
0.0607
3.7
8.4
36.2
48
73
93


 2*
0.0796



21
36
49


3
0.0966
0.5
1.2
5.0
27
51
75


 4*
0.1947



8
28
62


 5*
0.0927



24
45
66


6
0.0509
2.1
4.9
20.8
49
69
85


 7*
0.2026



6
25
56


8
0.1444
1.5
3.5
15.0
18
47
84


9
0.2061
0.3
0.7
3.2
7
29
67


10 
0.0968
2.2
5.0
21.3
31
60
88


11 
0.2283
0.6
1.5
6.2
6
28
71


12 
0.3679
0.3
0.8
3.3
1
13
59


13 
0.3982
0.2
0.4
1.8
1
11
54


14*
0.0791



7
12
17





*samples in which initial reduction of concentration of SkQ1 exceeds 20%.






Conclusion: Compositions 1 and 6 provide greater SkQ1 stability levels.


Experimental example 2
File Cos30-Cos33

The basic composition (BC2) used in this experiment was a composition with the following ingredients:


Biocol LG—2.9%


Propylene glycol—3%


Pentylene glycol—5%


Ethyl hexyl glycerine—0.3%


SkQ1—3 mcM


The experiment also used an additional mixture of components (DSK) with the following ingredients:


Caprylyl methicone (Silsoft 034) 0.5%


Hydrogenated polydecene (Nexbase) 0.5%


The following versions of compositions were examined:














Number
Symbol



of compo-
of


sition
composition
Ingredients

















1
1
BC2 + hydrogenated polydecene (Nexbase)




1%


2
2
BC2 + caprylyl methicone (Silsoft 034) 1%


3
3
BC2 + DSK


4
4.1
BC2 + DSK + perfume composition




Pampleflor 34017 (Floressence) 0.1%


5
4.2
+ perfume composition Olive Fresh 226864




(Fragrance Oils (International) Limited




0.1%)


6
4.3
BC2 + DSK + perfume composition




Freshness of Grass 10.01.0204 (AC Sense)




0.1%


7
5.1 Peptiskin
BC2 + DSK + Arginine/lysine polypeptide



2%
(Peptiskin) 2%


8
5.2 Galutine
BC2 + DSK + Caprylic/Capric triglyceride



In-Tuse
(and) Spilanthes Acmella Flower Extract




(Gatuline In-Tense) 2%


9
5.3
BC2 + DSK + Pisum sativum Extract (and)



Vegenensor
Sclerotium Gum (Vegetensor) 5%


10
5.4 Argireline
BC2 + DSK + Aqua (and) Acetyl




Hexapeptide-8 (Argireline) 5%


11
5.5 Ecoffea
BC2 + DSK + Aqua (and) Glycerine (and)





Coffea Arabica (Coffee) Seedcake Extract





(Ecoffea) 4%


12
5.6
BC2 + DSK + Aqua (and) Alcohol (and)



Cyclopeptide
Lecithin (and) Ectoin (and)




Cyclotetrapeptide-24 Aminocyclohexane




Carboxylate (RonaCare Cyclopeptide-5) 3%


13
5.7 Moremine
BC2 + DSK + Sorbitol (and)




Methylchromone (RonaCare Luremin) 3%.


14
5.8 Dermocea
BC2 + DSK + Aqua (and) Sucrose (and)





Meristotheca Dakarensis Extract (and) Jania






Rubens Extract (Dermocea) 2%.



15
5.10 Cdermo
BC2 + DSK + Mica (and) Cl77891 (TiO2)



Oriental Beige
(and) Cl77491 (FeO)(Colorona Oriental




Beige) 0.6%


16
5.11 Ranaflair
BC2 + DSK + Bismuth Oxychloride




(RonaFlair MTU) 2%


17
5.12 Red Gold
BC2 + DSK + Mica (and) Titanium Dioxide




(and) Iron Oxide (Colorona Red Gold) 0.6%









Brief Description:


Experiment start date: 27.07.2012


0-point: Samples of cosmetics after manufacture and weighing were stored at −78 . . . -80° C. in dark plastic bottles 2 ml in volume until the analysis was conducted.


3.5 months, 60° C.: Samples of cosmetics after manufacture and weighing were stored for 3.5 months at 60° C. in dark plastic bottles 2 ml in volume, then stored at −78 . . . -80° C. until the analysis was conducted.


Test preparation: Heating at room temperature (30 min), extraction with methanol (1 ml, vortex, thermoshaker 1 hour 1,200 rpm), centrifuging (15 min 13,400 rpm)


Numerical Data

















27.07.12





0 point
3.5 months, 60 C.



2
4


















Composition
seriesID
vial
T, uG/ml
m, mg
iG/g
seriesID
vial
T, uG/ml
m, mg
uG/g
Residue, %





















1
cos030
a011
lost
95.80

cos031
h081
0.0279
105.17
0.266



2

b021
0.6786
104.32
6.505

i091
0.0082
92.61
0.088
1.2%


3

c031
0.4781
91.30
5.237

j101
0.0066
105.9
0.062
1.4%


4.1

d041
0.5498
99.57
5.521
cos032
a011
0.0076
95.64
0.079
1.4%


4.2

e051
0.4554
105.03
4.336

b021
0.0130
106.3
0.122
2.8%


4.3

f061
0.3441
111.16
3.095

c031
0.0077
89.22
0.086
2.2%


5.1 Peptiskin 2%

g071
0.5889
93.07
6.328

d041
0.0167
103.07
0.162
2.8%


5.2 Galutine In-Tuse

h081
0.5649
100.21
5.638

e051
0.0656
100.66
0.652
11.6%


5.3 Vegenensor

i091
0.4475
107.71
4.155

f061
0.0005
101.35
0.005
0.1%


5.4 Agririlene

j101
0.6717
101.38
6.625

g071
0.1048
114.17
0.918
15.6%


5.5 Ecoffea
cos031
a011
0.8353
110.28
7.574

h081
0.0396
106.27
0.373
4.7%


5.6 Cyclopeptide

b021
0.4856
105.34
4.610

i091
0.0064
99.29
0.064
1.3%


5.7 Moremine

c031
0.3792
97.06
3.906

j101
0.0204
97.45
0.209
5.4%


5.8 Dermocea

d041
0.3749
94.68
3.960
cos033
a011
0.0111
95.88
0.116
3.0%


5.10 Cdermo Oriental Beige

e051
0.5295
91.43
5.791

b021
0.0077
108.17
0.071
1.4%


5.11 Ranaflair

f061
0.7489
107.80
6.947

c031
0.1246
99.32
1.255
16.6%


5.12 Red Gold

g071
0.7832
101.68
7.702

d041
0.0509
91.41
0.557
6.5%









Discussion of results: Accelerated storage of cosmetic compositions at 60° C. is not a sufficiently reliable way of studying the stability of mitochondrial antioxidants within a cosmetic product. However, with a specified level of reliability, the speed constant assessment values obtained can be used to extrapolate to real conditions of storage. The results of this extrapolation are shown in the table:
















25 C.
4 C.














Time taken

Time taken





to realise

to realise




20% loss
Portion of PDTF
20% loss
Portion of PDTF



60 C.
PDTF,
remaining after
PDTF,
remaining after


Composition
k′ month−1
months
year of storage, %
months
year of storage, %















1
0.865203
3
40
13
81


2
1.229426
2
27
9
74


3
1.267534
2
26
9
73


4.1
1.21339
2
28
9
74


4.2
1.020196
2
34
11
78


4.3
1.02377
2
34
11
78


5.1 Peptiskin
1.047184
2
33
10
77


2%


5.2 Galutine
0.616354
4
52
18
86


In-Tuse


5.3
1.920751
1
13
6
62


Vegenensor


5.4
0.564688
4
55
19
87


Argirelene


5.5. Ecoffea
0.860257
3
40
13
81


5.6
1.222029
2
27
9
74


Cyclopeptide


5.7
0.836553
3
41
13
81


Moremine


5.8
1.008688
3
34
11
78


Dermocea


5.10 Cdermo
1.257537
2
26
9
73


Oriental


Beige


5.11.
0.488907
5
60
22
89


Ranaflair


5.12 Red
0.750477
3
45
14
83


Gold









Therefore, for samples 5.2, 5.4 and 5.11, we unexpectedly obtained results indicating that these compositions possibly retain more than 50% of the active substance over a year of storage at room temperature.


Experimental Example 3
File Cos34-Cos36
Study of Degradation of PDTF in Ingredients of Cosmetic Compositions at 42° C. and 60° C., Time Range 10 Days
Start of Experiment 01/03/2013

The basic composition (BC3) used in this experiment was a composition with the following ingredients:


Methocel 40-202 (hydroxypropyl methyl cellulose) 2%


Propylene glycol 3%


Pentylene glycol 5%


Ethyl hexyl glycerine 0.3%


SkQ1 1.5 mcM


The basic composition (BC4) used in this experiment was a composition with the following ingredients:


Methocel 2%


Caprylyl methicone (Silsoft 034) 0.5%


Hydrogenated polydecene (Nexbase) 0.5%


Propylene glycol 3%


Pentylene glycol 5%


Ethyl hexyl glycerine 0.3%


SkQ1 1.5 mcM


Basic composition BC5, with the following ingredients, was also used:


Biocol LG—2.9%


Propylene glycol 3%


Pentylene glycol 5%


Ethyl hexyl glycerine 0.3%


SkQ1 1.5 mcM


Basic composition BC6, with the following ingredients, was also used:


Biocol LG—2.9%


Propylene glycol 3%


Pentylene glycol 5%


Ethyl hexyl glycerine 0.3%


SkQ1 1.5 mcM


Caprylyl methicone (Silsoft 034) 0.5%


Hydrogenated polydecene (Nexbase) 0.5%


The following versions of compositions were examined:














Number




of
Compo-


compo-
sition


sition
code
Ingredients

















1
1.1
BC3 + Gatuline In-Tense 1.8% + RonaCare Luremin




3%


2
1.2
BC3 + Gatuline In-Tense 1.8% + Ecoffea 4%


3
1.3
BC3 + Argireline 5% + RonaCare Luremin 3%.


4
1.4
BC3 + Argireline 5% + Ecoffea 4%.


5
1.5
BC3 + Ecoffea 4% + RonaCare Luremin 3%.


6
2.1
BC4 + Gatuline In-Tense 1.8% + RonaCare Luremin




3%.


7
2.2
BC4 + Gatuline In-Tense 1.8% + Ecoffea 4%.


8
2.3
BC4 + Argireline 5% + RonaCare Luremin 3%.


9
2.4
BC4 + Argireline 5% + Ecoffea 4%.


10
2.5
BC4 + Ecoffea 4% + RonaCare Luremin 3%.


11
3.1
BC5 + Gatuline In-Tense 1.8% + RonaCare Luremin




3%


12
3.2
BC5 + Gatuline In-Tense 1.8% + Ecoffea 4%.


13
3.3
BC5 + Argireline 5% + RonaCare Luremin 3%.


14
3.4
BC5 + Argireline 5% + Ecoffea 4%.


15
3.5
BC5 + Ecoffea 4% + RonaCare Luremin




3%.


16
4.1
BC6 + Gatuline In-Tense 1.8% + RonaCareLuremin




3%.


17
4.2
BC6 + Gatuline In-Tense 1.8% + Ecoffea 4%.


18
4.3
BC6 + Argireline 5% + RonaCare Luremin 3%.


19
4.4
BC6 + Argireline 5% + Ecoffea 4%.


20
4.5
BC6 + Ecoffea 4% + RonaCare Luremin 3%.


21
5.1
BC3 + Argireline 5% + RonaCare Luremin 3% +




Ecoffea 4%.


22
5.2
Methocel 0.2% + propylene glycol 3% + pentylene




glycol 5% + ethyl hexyl glycerine 0.3% + SkQ




(15 mcM).









Brief Description:


Experiment Start Date: 01.03.2013


0-points: Samples of cosmetics after manufacture and weighing were stored at −78 . . . -80° C. in dark plastic bottles 2 ml in volume until the analysis was conducted.


Time points: Samples of cosmetics after manufacture and weighing were stored for 3.5 months at 42° C. or 60° C. in dark plastic bottles 2 ml in volume, then stored at −78 . . . -80° C. until the analysis was conducted.


Test preparation: Heating at room temperature (30 min), extraction with methanol (1 ml, vortex, thermoshaker), centrifuging (15 min 13,400 rpm)


Conclusion: At 60° C. more than 35% SkQ1 remained in compositions 2, 4, 5, 7, 11, 16, 17 and 21; for storage without heating (over 70% retained)—compositions 3, 11, 14, 15, 17 and 21, but in this case the highest substance content (over 0.5 mcg/g) at the initial point was observed in compositions 5, 9, 10, 12-19 and 22.


Experimental Example 4
File Cos42 . . .

The following versions of compositions were examined:














Number
Symbol of



of composition
composition
Ingredients







3
Methocel
Methocel 2%




Propylene glycol 3%




Pentylene glycol 5%




Ethyl hexyl glycerine 0.3%




SkQ1 15 mcM


4
Biocol 2.5%
Biocol LG 2.5%,



Silsoft 034
propylene glycol 3%,



and Nexbase
pentylene glycol 5%,




ethyl hexyl glycerine 0.3%,




SkQ 15 mcM.


5
Biocol 2.9%
Biocol LG 2.9%



Silsoft 034
Propylene glycol 3%



and Nexbase
Pentylene glycol 5%




Ethyl hexyl glycerine 0.3%




Ethyl hexyl glycerine 0.3%,




caprylyl methicone (Silsoft




034) 0.5%




Hydrogenated polydecene




(Nexbase) 0.5%




SkQ1-15 mcM









Numerical Data


In brief:












Cos042; SkQ1; Analysis Date: 27/5/2013 13:34















t,

Ave
Rel



Sample
m, mg
° C.
uG(SkQ1)/G(cosm)
Dev
Err
Symbol of composition
















3.1
103.13
−78
0.982
0.022
2.3%
Methocel


3.2
96.32
+60
0.146
0.023
15.7%


3.3
97.25
+42
0.387
0.040
10.3%


4.1
103.62
−78
3.879
0.057
1.5%
Biocol 2.5% Silsoft 034 and Nexbase


4.2
103.02
+60
1.283
0.040
3.1%


4.3
103.07
+42
3.356
0.056
1.7%


5.1
103.60
−78
4.044
0.102
2.5%
Biocol Gel Biocol 2.9% Silsoft 034 Nexbase


5.2
96.12
+60
2.006
0.041
2.0%


5.3
95.69
+42
1.839
0.032
1.7%





Notes


1. “T, uG/mL”—concentration determined according to result of single injection; “T(ave), uG/mL”—average concentration of PDTF; “Ave Dev., uG/mL”—average deviation in concentration of PDTF; “Rel. Err”—relative average deviation expressed as a percentage










Brief Description:


The quantitative analysis was conducted using the UPLC-MS/MS method with PDTF-d15 of a known concentration as the internal standard and 3-chlorperbenzoic acid as the oxidising agent. The analysis was conducted in accordance with the method shown in the PCS for Visomytin eye drops.


1 analytical sample was prepared from each sample (extraction of 1 ml of methanol 12 hours, thermoshaker (27° C. 1400 rpm), centrifuging, preparation of analytical samples with dilution 5 times)


Experimental Example 4
File Cos44 . . .

In this experiment, with accelerated storage (at temperature +60° C.), the following composition (symbol Cos44) was used:

    • Biocol AX (Pectin, Xanthan gum) 2.9%
    • Propylene glycol 3%
    • Caprylyl methicone (Silsoft 034) 0.5%
    • Ethyl hexyl glycerine (Nexbase) 0.5%
    • Microcare IT (methylchloroisothiazolinone (and) methylisothiazolinone)
    • SkQ1 10 mcM


Here follow the introductory data for this experiment.















Composition identifier
Cos044


Specified substances, method
SkQ1, UPLC-MS/MS


Matrix
Gel extract 96% EtOH


Method of analysis (file name)
ND 0001355-131211 dated 13.12.11









Results of Analysis












Composition Cos44; experiment 60° C.;


Cos044; SkQ1
















T,
T(ave),
Ave Dev,
Rel


Sample
Date
Vial
uG/mL
uG/mL
uG/mL
Err





0 point
Oct. 28, 2013
11
0.4783
0.4927
0.0185
3.8%





0.5208





0.4797





0.4863





0.4944





0.5137





0.4805





0.5250





0.4554


1 point
Oct. 31, 2013
21
0.3261
0.3194
0.0092
2.9%





0.3139





0.3050





0.3167





0.3349





0.3284





0.3108





0.3088





0.3298


2 point
Nov. 5, 2013
31
0.2671
0.2495
0.0087
3.5%





0.2368





0.2325





0.2661





0.2544





0.2481





0.2437





0.2487





0.2481


3 point
Nov. 7, 2013
41
0.2477
0.2223
0.0053
2.4%





0.2236





0.2239





0.2173





0.2320





0.2254





0.2282





0.2172





0.2111









In brief:












Composition Cos44; experiment 60° C.;


Cos044; SkQ1;














mass,
uG(SkQ1)/
Ave Dev,
Rel


Sample
Date
mg
G(gel)
uG/G
Err





0 point
Oct. 28, 2013
104.64
4.71
0.18
3.8%


1 point
Oct. 31, 2013
109.45
2.92
0.08
2.9%


2 point
Nov. 5, 2013
109.39
2.28
0.08
3.5%


3 point
Nov. 7, 2013
104.94
2.12
0.05
2.4%





Notes


“T, uG/mL”—concentration determined according to result of single injection;


“T(ave), uG/mL”—average concentration of SkQ1;


“Ave Dev., uG/mL”—average deviation in concentration of SkQ1;


“Rel. Err”—relative average deviation expressed as a percentage










Conclusion: Extrapolation of the data obtained for real storage temperatures of cosmetic products indicates that 50% of substance is lost over 50-100 days of storage at 25 C or 200-400 days of storage at 4 C.


Brief Description:


The quantitative analysis was conducted using the UPLC-MS/MS method with SkQ1-d15 of a known concentration as the internal standard and 3-chlorperbenzoic acid as the oxidising agent. The analysis was conducted in accordance with the method shown in the PCS for Visomytin eye drops.


From each sample of solution, a drop was produced for 1 analytical sample.


S/Sstd for standard samples was averaged for 24 injections (no ejections). Average value of S/Sstd for standard samples, equal to 2.162+/−0.124, used for calculating SkQl concentration in solutions studied.

Claims
  • 1. Composition for cosmetic use, comprising mitochondrial antioxidant in concentration from 1 nM to 1 mM, with condition that during storage of composition for at least 30 days at temperature in excess of 0° C., the ingredients of the composition retained not less than 70% of the initial concentration of mitochondrial antioxidant.
  • 2. Composition according to claim 1, comprising gel-forming component
  • 3. Composition according to claim 2, characterised in that the gel-forming components are macromolecular colloids or associated organic colloids, or aggregates formed by non-organic molecules and particles (non-organic colloids).
  • 4. Composition according to claim 3, characterised in that the gel-forming components are synthetic polymers and co-polymers (polyethylene glycol, polyacrylic acid and polyacrylates) or cellulose and its derivatives), or natural resins (guar and xanthan gum, carrageenan etc.), or polysaccharides (starch and starch derivatives, alginates), or proteins and hydrolysed proteins, or a mixture of various gelling agents.
  • 5. Composition according to claims 2-4, characterised in that the gel-forming component includes carob tree gum.
  • 6. Composition according to claims 2-5, characterised in that the gel-forming component includes pectin.
  • 7. Composition according to claims 2-6, characterised in that the gel-forming component includes sodium alginate.
  • 8. Composition according to claims 1-7, comprising a hydrophilic emollient,
  • 9. Composition according to claim 8, comprising a polyol-based emollient.
  • 10. Composition according to claim 8, comprising an emollient based on water-soluble esters.
  • 11. Composition according to claim 8, comprising an emollient based on vegetable extracts.
  • 12. Composition according to claims 1-7, comprising a hydrophobic emollient.
  • 13. Composition according to claim 12, characterised in that the emollient includes one or more substances from the following list: natural or synthetic fats, oils, waxes; hydrocarbons, higher carbonic acids and alcohols, silicon.
  • 14. Composition according to claim 13, comprising hydrogenated polydecene and caprylyl methicone.
  • 15. Composition according to claim 12, comprising caprylic/capric triglycerides.
  • 16. Composition according to claims 1-13, comprising one or more multi-functional components with antimicrobial activity.
  • 17. Composition according to claims 1-16, comprising an additional active substance (active ingredient).
  • 18. Composition according to claim 17, characterised in that one of the additional active substances is acmella extract
  • 19. Composition according to claims 1-18, characterised in that the mitochondrial antioxidant is a compound of general formula 1:
  • 20. Composition according to claim 22, characterised in that the mitochondrial antioxidant is a SkQ1 compound:
  • 24. Cosmetic composition according to claim 23, characterised in that its ingredients of which include mitochondrial antioxidant SkQ1, a gelling agent (carob tree gum, pectin, sodium alginate), an emollient (hydrogenated polydecene and/or caprylyl methicone), ethyl hexyl glycerine, pentylene glycol, propylene glycol.
PCT Information
Filing Document Filing Date Country Kind
PCT/IB2015/001030 2/25/2015 WO 00
Provisional Applications (1)
Number Date Country
61944205 Feb 2014 US